biology-news-1/study-shows-cancer-vaccines-led-to-long-term-survival-for-patients-with-metastatic-melanoma-9391-2/;msg90356

Breaking Biology Technology:Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4 CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2 CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4 Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2 Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3

[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics [0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner [0] Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 [0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas

Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2 NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2 ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2 ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3 Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 1 Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 2 Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 3 Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 1 Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 2 Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 3 Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 4 Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 5 Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 6 NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 1 NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 2 NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 3 NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 4 NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 5

[0] National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards [0] NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock [0] ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference